Literature DB >> 9678766

Apoptosis of vascular smooth muscle cells in atherosclerosis.

M R Bennett1, J J Boyle.   

Abstract

Apoptosis (programmed cell death) of vascular smooth muscle cells and macrophages has recently been demonstrated in the following: (a) human atherosclerotic plaques; (b) physiological remodelling of the vessel; and (c) a variety of disease states. Apoptosis is a highly regulated mechanism of death, controlled by the interactions between the following: (i) cellular receptors; (ii) cytoplasmic and nuclear gene products; and (iii) the local cytokine and cellular environment within the plaque. The knowledge of the key regulators of apoptosis does, however, offer novel therapeutic targets in both the prevention and treatment of atherosclerosis.

Entities:  

Mesh:

Year:  1998        PMID: 9678766     DOI: 10.1016/s0021-9150(98)00013-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Vascular smooth muscle cell apoptosis in atherosclerosis.

Authors:  J J Boyle
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

2.  Rapid development of vein graft atheroma in ApoE-deficient mice.

Authors:  H Dietrich; Y Hu; Y Zou; U Huemer; B Metzler; C Li; M Mayr; Q Xu
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Identification of small proline-rich repeat protein 3 as a novel atheroprotective factor that promotes adaptive Akt signaling in vascular smooth muscle cells.

Authors:  Amanda K Segedy; Amy L Pyle; Bin Li; Youmin Zhang; Vladimir R Babaev; Parmjit Jat; Sergio Fazio; James B Atkinson; MacRae F Linton; Pampee P Young
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-02       Impact factor: 8.311

4.  Increased expression and activation of stress-activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53.

Authors:  B Metzler; Y Hu; H Dietrich; Q Xu
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

5.  Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome.

Authors:  Xiaomin Zhang; Zengguang Xu; Li Zhou; Ying Chen; Meian He; Longxian Cheng; Frank B Hu; Robert M Tanguay; Tangchun Wu
Journal:  Cell Stress Chaperones       Date:  2010-03-19       Impact factor: 3.667

Review 6.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

7.  Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.

Authors:  Olivier E Pardo; Adeline Lesay; Alexandre Arcaro; Rita Lopes; Bee Ling Ng; Patricia H Warne; Iain A McNeish; Teresa D Tetley; Nicholas R Lemoine; Huseyin Mehmet; Michael J Seckl; Julian Downward
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  Inhibition of interleukin-1beta convertase is associated with decrease of neointimal hyperplasia after coronary artery stenting in pigs.

Authors:  Mariann Gyöngyösi; Wolfgang Sperker; Csaba Csonka; Diana Bonderman; Irene Lang; Christoph Strehblow; Christopher Adlbrecht; Maryam Shirazi; Ursula Windberger; Stephan Marlovits; Michael Gottsauner-Wolf; Paul Wexberg; Mark Kockx; Peter Ferdinandy; Dietmar Glogar
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

9.  Association with inflammatory cells and apolipoproteins to the progression of atherosclerosis.

Authors:  Hyun-Seon Eo; Kyung-Bok Lee; Ae-Kyeong Kim; Min-Hee Kim; Do-Hyung Kim; Dong-Ik Kim
Journal:  J Korean Surg Soc       Date:  2011-04-12

10.  Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions.

Authors:  Giovanni Almanzar; Robert Öllinger; Julianna Leuenberger; Elisabeth Onestingel; Barbara Rantner; Sarah Zehm; Benno Cardini; Ruurd van der Zee; Cecilia Grundtman; Georg Wick
Journal:  J Autoimmun       Date:  2012-08-15       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.